Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,539 | 9 | 79.8% |
| Food and Beverage | $390.45 | 18 | 20.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus Corporation of the Americas | $1,007 | 10 | $0 (2024) |
| Medtronic, Inc. | $560.11 | 2 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $147.01 | 3 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $126.26 | 8 | $0 (2021) |
| AbbVie Inc. | $33.52 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.54 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $24.35 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $667.77 | 3 | Medtronic, Inc. ($560.11) |
| 2023 | $1,030 | 11 | Olympus Corporation of the Americas ($899.25) |
| 2022 | $71.86 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($31.54) |
| 2021 | $130.51 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($96.99) |
| 2020 | $29.27 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($29.27) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $35.07 | General |
| 12/04/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $525.04 | General |
| 03/19/2024 | Olympus Corporation of the Americas | VISIGLIDE (Device) | Travel and Lodging | In-kind items and services | $107.66 | General |
| Category: Endotherapy | ||||||
| 10/01/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device) | Travel and Lodging | In-kind items and services | $50.25 | General |
| Category: Endotherapy | ||||||
| 09/30/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device) | Travel and Lodging | In-kind items and services | $30.80 | General |
| Category: Endotherapy | ||||||
| 09/30/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Endotherapy | ||||||
| 09/30/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device) | Travel and Lodging | In-kind items and services | $15.40 | General |
| Category: Endotherapy | ||||||
| 09/30/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device) | Travel and Lodging | In-kind items and services | $15.40 | General |
| Category: Endotherapy | ||||||
| 09/30/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Endotherapy | ||||||
| 09/27/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Endotherapy | ||||||
| 07/18/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device), DISPOSABLE DISTAL ATTACHMENT | Travel and Lodging | In-kind items and services | $724.63 | General |
| Category: Endotherapy | ||||||
| 07/18/2023 | Olympus Corporation of the Americas | VISIGLIDE (Device), DISPOSABLE DISTAL ATTACHMENT | Travel and Lodging | In-kind items and services | $35.00 | General |
| Category: Endotherapy | ||||||
| 05/19/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 04/26/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 03/31/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/14/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 03/11/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Immunology | ||||||
| 11/29/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Gastroenterology | ||||||
| 10/14/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Gastroenterology | ||||||
| 08/31/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Gastroenterology | ||||||
| 05/25/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Gastroenterology | ||||||
| 05/25/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Gastroenterology | ||||||
| 03/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 136 | 138 | $77,650 | $13,366 |
| 2020 | 1 | 11 | 12 | $3,850 | $2,007 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 29 | 29 | $29,812 | $5,762 | 19.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $7,659 | $3,027 | 39.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 36 | 38 | $21,774 | $2,616 | 12.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $18,055 | $1,859 | 10.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 25 | 25 | $350.00 | $101.91 | 29.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 12 | $3,850 | $2,007 | 52.1% |
About Mihir Brahmbhatt
Mihir Brahmbhatt is a Internal Medicine healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1275915506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mihir Brahmbhatt has received a total of $1,930 in payments from pharmaceutical and medical device companies, with $667.77 received in 2024. These payments were reported across 27 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($1,539).
As a Medicare-enrolled provider, Brahmbhatt has provided services to 147 Medicare beneficiaries, totaling 150 services with total Medicare billing of $15,374. Data is available for 2 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Springfield, MO
- Active Since 06/23/2015
- Last Updated 09/14/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1275915506
Products in Payments
- VISIGLIDE (Device) $1,007
- OCALIVA (Drug) $147.01
- XIFAXAN (Drug) $126.26
- LINZESS (Drug) $33.52
- ENTYVIO (Biological) $31.54
- STELARA (Biological) $24.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372